197 related articles for article (PubMed ID: 32754266)
1. Fructose-1, 6-bisphosphatase 1 interacts with NF-κB p65 to regulate breast tumorigenesis via PIM2 induced phosphorylation.
Lu C; Ren C; Yang T; Sun Y; Qiao P; Han X; Yu Z
Theranostics; 2020; 10(19):8606-8618. PubMed ID: 32754266
[No Abstract] [Full Text] [Related]
2. PIM2 interacts with tristetraprolin and promotes breast cancer tumorigenesis.
Ren C; Yang T; Qiao P; Wang L; Han X; Lv S; Sun Y; Liu Z; Du Y; Yu Z
Mol Oncol; 2018 May; 12(5):690-704. PubMed ID: 29570932
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of HSF1 by PIM2 Induces PD-L1 Expression and Promotes Tumor Growth in Breast Cancer.
Yang T; Ren C; Lu C; Qiao P; Han X; Wang L; Wang D; Lv S; Sun Y; Yu Z
Cancer Res; 2019 Oct; 79(20):5233-5244. PubMed ID: 31409638
[TBL] [Abstract][Full Text] [Related]
4. A Noncanonical Role of Fructose-1, 6-Bisphosphatase 1 Is Essential for Inhibition of Notch1 in Breast Cancer.
Lu C; Ren C; Yang T; Sun Y; Qiao P; Wang D; Lv S; Yu Z
Mol Cancer Res; 2020 May; 18(5):787-796. PubMed ID: 32041737
[TBL] [Abstract][Full Text] [Related]
5. Positive regulation of PFKFB3 by PIM2 promotes glycolysis and paclitaxel resistance in breast cancer.
Lu C; Qiao P; Sun Y; Ren C; Yu Z
Clin Transl Med; 2021 Apr; 11(4):e400. PubMed ID: 33931981
[TBL] [Abstract][Full Text] [Related]
6. PIM2-mediated phosphorylation of hexokinase 2 is critical for tumor growth and paclitaxel resistance in breast cancer.
Yang T; Ren C; Qiao P; Han X; Wang L; Lv S; Sun Y; Liu Z; Du Y; Yu Z
Oncogene; 2018 Nov; 37(45):5997-6009. PubMed ID: 29985480
[TBL] [Abstract][Full Text] [Related]
7. Fructose-1,6-bisphosphatase is a novel regulator of Wnt/β-Catenin pathway in breast cancer.
Li K; Ying M; Feng D; Du J; Chen S; Dan B; Wang C; Wang Y
Biomed Pharmacother; 2016 Dec; 84():1144-1149. PubMed ID: 27780144
[TBL] [Abstract][Full Text] [Related]
8. Fructose-1,6-bisphosphatase loss modulates STAT3-dependent expression of PD-L1 and cancer immunity.
Wang B; Zhou Y; Zhang J; Jin X; Wu H; Huang H
Theranostics; 2020; 10(3):1033-1045. PubMed ID: 31938049
[No Abstract] [Full Text] [Related]
9. PIM2 promotes hepatocellular carcinoma tumorigenesis and progression through activating NF-κB signaling pathway.
Tang X; Cao T; Zhu Y; Zhang L; Chen J; Liu T; Ming X; Fang S; Yuan YF; Jiang L; Huang JD; Guan XY
Cell Death Dis; 2020 Jul; 11(7):510. PubMed ID: 32641749
[TBL] [Abstract][Full Text] [Related]
10. Negative regulation of AMPKα1 by PIM2 promotes aerobic glycolysis and tumorigenesis in endometrial cancer.
Han X; Ren C; Yang T; Qiao P; Wang L; Jiang A; Meng Y; Liu Z; Du Y; Yu Z
Oncogene; 2019 Sep; 38(38):6537-6549. PubMed ID: 31358902
[TBL] [Abstract][Full Text] [Related]
11. Invalidation of mitophagy by FBP1-mediated repression promotes apoptosis in breast cancer.
Liu Y; Jiang Y; Wang N; Jin Q; Ji F; Zhong C; Zhang Z; Yang J; Ye X; Chen T
Tumour Biol; 2017 Jun; 39(6):1010428317708779. PubMed ID: 28653874
[TBL] [Abstract][Full Text] [Related]
12. PAK5-mediated phosphorylation and nuclear translocation of NF-κB-p65 promotes breast cancer cell proliferation in vitro and in vivo.
Zhang YC; Huo FC; Wei LL; Gong CC; Pan YJ; Mou J; Pei DS
J Exp Clin Cancer Res; 2017 Oct; 36(1):146. PubMed ID: 29041983
[TBL] [Abstract][Full Text] [Related]
13. Targeting NF-κB RelA/p65 phosphorylation overcomes RITA resistance.
Bu Y; Cai G; Shen Y; Huang C; Zeng X; Cao Y; Cai C; Wang Y; Huang D; Liao DF; Cao D
Cancer Lett; 2016 Dec; 383(2):261-271. PubMed ID: 27721021
[TBL] [Abstract][Full Text] [Related]
14. Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA.
Ryo A; Suizu F; Yoshida Y; Perrem K; Liou YC; Wulf G; Rottapel R; Yamaoka S; Lu KP
Mol Cell; 2003 Dec; 12(6):1413-26. PubMed ID: 14690596
[TBL] [Abstract][Full Text] [Related]
15. FBP1 modulates cell metabolism of breast cancer cells by inhibiting the expression of HIF-1α.
Shi L; He C; Li Z; Wang Z; Zhang Q
Neoplasma; 2017; 64(4):535-542. PubMed ID: 28485159
[TBL] [Abstract][Full Text] [Related]
16. E3 ubiquitin ligase UBR5 promotes pancreatic cancer growth and aerobic glycolysis by downregulating FBP1 via destabilization of C/EBPα.
Chen L; Yuan R; Wen C; Liu T; Feng Q; Deng X; Du Y; Peng X
Oncogene; 2021 Jan; 40(2):262-276. PubMed ID: 33122826
[TBL] [Abstract][Full Text] [Related]
17. Proviral insertion in murine lymphomas 2 (PIM2) oncogene phosphorylates pyruvate kinase M2 (PKM2) and promotes glycolysis in cancer cells.
Yu Z; Zhao X; Huang L; Zhang T; Yang F; Xie L; Song S; Miao P; Zhao L; Sun X; Liu J; Huang G
J Biol Chem; 2013 Dec; 288(49):35406-16. PubMed ID: 24142698
[TBL] [Abstract][Full Text] [Related]
18. Targeted knockdown of polo-like kinase 1 alters metabolic regulation in melanoma.
Gutteridge RE; Singh CK; Ndiaye MA; Ahmad N
Cancer Lett; 2017 May; 394():13-21. PubMed ID: 28235541
[TBL] [Abstract][Full Text] [Related]
19. Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38.
Madrid LV; Mayo MW; Reuther JY; Baldwin AS
J Biol Chem; 2001 Jun; 276(22):18934-40. PubMed ID: 11259436
[TBL] [Abstract][Full Text] [Related]
20. BEX2 has a functional interplay with c-Jun/JNK and p65/RelA in breast cancer.
Naderi A; Liu J; Hughes-Davies L
Mol Cancer; 2010 May; 9():111. PubMed ID: 20482821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
